Assessment of Blood Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Patients With Non–Small Cell Lung Cancer With Use of a Next-Generation Sequencing Cancer Gene Panel

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

JAMA Oncology

Topics

Biology

Cancer Oncology

Medicine

Internal Medicine

Cancer Research

Show all topics

DOI

10.1001/jamaoncol.2018.7098

License

CC-BY

Other Formats

PDF